Osteopore Continues Growth Streak, Funds Innovation
Company Announcements

Osteopore Continues Growth Streak, Funds Innovation

Osteopore Ltd. (AU:OSX) has released an update.

Osteopore Ltd. has reported its 6th consecutive quarter of revenue growth with a significant 28% increase year-on-year and a 3% rise from the previous quarter. The company also successfully raised A$2.9 million through an Entitlement Offer, aiming to bolster its balance sheet and fund further sales, mergers, acquisitions, and research and development. Additionally, Osteopore has launched first-in-human clinical trials for knee preservation at the National University Hospital Singapore.

For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App